Business news – Page 91
-
Business
Dispute over Arkema finances
French speciality chemical company Arkema accused of misrepresenting business sold to investment firm last year
-
Opinion
New antibiotics: what's the hold up?
It’s more a research problem, than a commercial one, says Derek Lowe
-
Business
Alcohol dependence pill approved in EU
Selincro tablets from Lundbeck designed to reduce consumption of alcohol
-
Business
University to acquire Shell UK R&D site
Site at Thornton will become a science park under the stewardship of the University of Chester
-
Business
UK considers patent rule change for trials
Government to change law that organisations say makes the country less appealing as a location for clinical trials
-
Business
Dow rapped for $1bn tax scheme
Judge opines: ‘tax law deals in economic realities, not legal abstractions’
-
Business
Does chemical regulation boost innovation?
Report suggests that supply of innovation responds to extra demand created by new laws
-
Business
Talk of a $6.6bn deal for Elan
Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
-
Business
$595m octreotide deal grabs Roche
Company will get worldwide rights to oral formulation of growth hormone drug
-
Business
Merck resolves Vytorin case for $688m
Investors say the company knew about Enhance trial failure but withheld information
-
Business
BMS sells OTC drugs for $482m
Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
-
Business
Biogen buys Tysabri from Elan for $3.25bn
Elan earns huge cash injection for blockbuster drug
-
Business
GSK commits to AllTrials data disclosure
Company will begin publishing all clinical study reports
-
Business
Reach reviewed: no change required
But disproportionate cost of compliance for small and medium size companies should be reduced, European commission says
-
Business
EU proposes neonicotinoid pesticide ban
Clothianidin, thiamethoxam and imidacloprid at centre of debate over declining bee populations
-
Business
Zoetis IPO launches at $2.2bn
Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
-
Business
DCD in New Zealand milk
Dicyandiamide poses no food risk but fertiliser companies have suspended sales
-
Business
Unrest over US gas exports
Dow says exports will increase cost of gas and decrease price stability